Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation
- 8 May 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (18) , 2248-2253
- https://doi.org/10.1161/01.cir.103.18.2248
Abstract
Background—The mechanism of the antithrombotic action of statins is unclear. The aim of this study was to evaluate the effects of simvastatin on the coagulation process at sites of microvascular in...Keywords
This publication has 26 references indexed in Scilit:
- State-of-the-Art-Review : Statins Induce Hypothrombotic States?Clinical and Applied Thrombosis/hemostasis, 2000
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Increased thrombin generation and complement activation in patients with type IIA hyperlipoproteinemia: effects of simvastatin treatmentCurrent Therapeutic Research, 1997
- The Coagulation ExplosionaAnnals of the New York Academy of Sciences, 1994
- [2] Human plasma factor XIII: Subunit interactions and activation of zymogenPublished by Elsevier ,1993
- THROMBOXANE A2 IN SKIN-BLEEDING-TIME BLOOD AND IN CLOTTED VENOUS BLOOD BEFORE AND AFTER ADMINISTRATION OF ACETYLSALICYLIC ACIDThe Lancet, 1983
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulationThrombosis Research, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970